Piramal Pharma Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 34.80% of Piramal Pharma, FIIs hold 13.65%, DIIs hold 14.43% and the public holds 36.72%. Promoter holding was unchanged from Jun 2026.
Get an alert when Piramal Pharma reports results or its shareholding changes. Free account.
Promoters
34.80%
unchanged QoQ
FIIs
13.65%
+1.14 pp QoQ
DIIs
14.43%
−0.14 pp QoQ
Public
36.72%
−0.90 pp QoQ
Piramal Pharma shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Others | Shareholders |
|---|---|---|---|---|---|---|
| Sep 2026 | 34.80% | 13.65% | 14.43% | 36.72% | 0.40% | 4,13,197 |
| Jun 2026 | 34.80% | 12.51% | 14.57% | 37.62% | 0.48% | 4,61,096 |
| Mar 2026 | 34.85% | 30.17% | 15.61% | 19.01% | 0.34% | 4,50,661 |
| Dec 2025 | 34.85% | 29.66% | 15.68% | 19.35% | 0.44% | 4,53,830 |
| Sep 2025 | 34.85% | 30.27% | 14.89% | 19.46% | 0.51% | 4,62,511 |
| Jun 2025 | 34.85% | 30.86% | 14.25% | 19.46% | 0.57% | 4,58,430 |
| Mar 2025 | 34.94% | 31.49% | 14.78% | 18.42% | 0.34% | 4,32,843 |
| Dec 2024 | 34.94% | 31.68% | 14.09% | 18.85% | 0.40% | 4,18,442 |
| Sep 2024 | 34.94% | 31.73% | 13.80% | 19.06% | 0.45% | 3,59,751 |
| Jun 2024 | 34.94% | 31.41% | 12.95% | 20.20% | 0.47% | 3,06,398 |
| Mar 2024 | 35.02% | 30.58% | 12.12% | 21.89% | 0.37% | 2,97,996 |
| Dec 2023 | 35.02% | 32.51% | 9.68% | 22.41% | 0.38% | 2,92,312 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others) · Others. Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹32.57k cr, the promoter group's 34.80% stake is worth ₹11.34k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Piramal Pharma shareholding: common questions
What is the promoter holding in Piramal Pharma?
Promoters hold 34.80% of Piramal Pharma as of Sep 2026. Their stake was unchanged from Jun 2026.
How much do FIIs hold in Piramal Pharma?
Foreign institutional investors (FIIs) held 13.65% of Piramal Pharma in Sep 2026, +1.14 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Piramal Pharma?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 14.43% of Piramal Pharma in Sep 2026, −0.14 pp versus Jun 2026.
Is the promoter holding in Piramal Pharma pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Piramal Pharma.
How has Piramal Pharma's promoter holding changed in the last year?
Promoter holding moved from 34.85% in Sep 2025 to 34.80% in Sep 2026 (−0.05 pp).
How many shareholders does Piramal Pharma have?
Piramal Pharma had 4,13,197 shareholders in Sep 2026, compared with 4,61,096 in Jun 2026.